Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
The New England Journal of Medicine|November 18, 2014
Angiotensin blockade in late autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Arlene B Chapman, et al.
Plos One|May 27, 2021
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic reviewPatrizia Natale, Elyssa Hannan, Bénédicte Sautenet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2014
Liver involvement in early autosomal-dominant polycystic kidney diseaseMarie C Hogan, Kaleab Abebe, Vicente E Torres, et al.
Contemporary Clinical Trials|August 2, 2015
Closeout of the HALT-PKD trialsCharity G Moore, Susan Spillane, Gertrude Simon, et al.
Kidney International|June 20, 2024
A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protectionHiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, et al.
The New England Journal of Medicine|November 18, 2014
Blood pressure in early autosomal dominant polycystic kidney diseaseRobert W Schrier, Kaleab Z Abebe, Ronald D Perrone, et al.
Kidney International Reports|June 2, 2018
Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney DiseaseTaimur Dad, Kaleab Z Abebe, K Ty Bae, et al.
Kidney International Reports|February 24, 2025
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKDRosanna Cazzolli, Angela Ju, Patrizia Natale, et al.
Nature Reviews. Nephrology|May 24, 2019
International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young peopleCharlotte Gimpel, Carsten Bergmann, Detlef Bockenhauer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 8, 2023
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKDWillem Collier, Lesley A Inker, Benjamin Haaland, et al.
Pageof 16